Johnson & Johnson is one of the world’s leading consumer health companies. With 2014 sales of US$8.4 billion, the company is well on its way to reaching its pre-production issue levels. However, with competitors making increasingly bold moves to challenge it at the top, J&J will need to increase investment and potentially even look to acquisitions to maintain its standing in an industry it led for nearly a decade.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Euromonitor International's report on Johnson & Johnson Inc delivers a detailed strategic analysis of the company's business, examining its performance in the Vitamins and Dietary Supplements market and the global economy.
Company and market share data provide a detailed look at the financial position of Johnson & Johnson Inc, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Johnson & Johnson Inc.
Euromonitor International's company profile reports are written by our Vitamins and Dietary Supplements research team, a dedicated group of analysts that knows the industry inside and out.
Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.
Reports are delivered in PDF format and can be downloaded from your online account immediately after purchase.